Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chimera Antigen Receptor (CAR)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06590246
What this trial is testing

Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Shanghai AbelZeta Ltd. 121
Early research (Phase 1)Not Yet RecruitingNCT05181501
What this trial is testing

Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2)

Who this might be right for
Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd. 20
Testing effectiveness (Phase 2)UnknownNCT04162119
What this trial is testing

Safety and Efficiency Study of BCMA-PD1-CART Cells in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT06006403
What this trial is testing

Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm

Who this might be right for
Acute Myeloid LeukemiaBlastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Relapse Leukemia+1 more
Chongqing Precision Biotech Co., Ltd 5
Testing effectiveness (Phase 2)Looking for participantsNCT06895473
What this trial is testing

Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

Who this might be right for
Hematopoietic and Lymphatic System Neoplasm
OHSU Knight Cancer Institute 26
Early research (Phase 1)Looking for participantsNCT06964737
What this trial is testing

Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas

Who this might be right for
Recurrent Malignant GliomaRecurrent WHO Grade 3 GliomaRecurrent WHO Grade 4 Glioma+3 more
Ohio State University Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07569965
What this trial is testing

Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCL

Who this might be right for
Mantle Cell Lymphoma (MCL)
Miltenyi Biomedicine GmbH 52
Early research (Phase 1)Looking for participantsNCT06287528
What this trial is testing

19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Philadelphia-Negative ALLPhiladelphia-Positive ALLRelapsed ALL, Adult+3 more
Memorial Sloan Kettering Cancer Center 18
Early research (Phase 1)Looking for participantsNCT07300683
What this trial is testing

Anti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma

Who this might be right for
T Cell Acute Lymphoblastic LeukemiaT Cell Lymphoblastic Lymphoma
University College, London 24
Early research (Phase 1)UnknownNCT03599375
What this trial is testing

Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, B-Cell
jiuwei cui 20
Early research (Phase 1)Ended earlyNCT03502577
What this trial is testing

BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 19
Not applicableTemporarily pausedNCT03752541
What this trial is testing

Efficacy and Safety Evaluation of BCMA-UCART

Who this might be right for
Multiple Myeloma
Bioray Laboratories 20
Testing effectiveness (Phase 2)WithdrawnNCT07006805
What this trial is testing

RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis (RMS)Progressive Multiple Sclerosis (PMS)Multiple Sclerosis - Relapsing Remitting+4 more
Cabaletta Bio
Early research (Phase 1)Looking for participantsNCT04995003
What this trial is testing

HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

Who this might be right for
SarcomaHER-2 Protein OverexpressionOsteosarcoma+5 more
Baylor College of Medicine 25
Testing effectiveness (Phase 2)Looking for participantsNCT06854159
What this trial is testing

Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+1 more
University of California, Davis 34
Early research (Phase 1)UnknownNCT04107142
What this trial is testing

Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour

Who this might be right for
Colorectal CancerTriple Negative Breast CancerSarcoma+3 more
CytoMed Therapeutics Pte Ltd 10
Testing effectiveness (Phase 2)Looking for participantsNCT06267729
What this trial is testing

Study of AZD0754 in Participants With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
AstraZeneca 60
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Early research (Phase 1)UnknownNCT02844062
What this trial is testing

Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Beijing Sanbo Brain Hospital 20
Early research (Phase 1)WithdrawnNCT04106076
What this trial is testing

Phase I Study of UCART123 in Patient With Adverse Genetic Risk Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukaemia
Cellectis S.A.
Next Page